Table 1 Clinicopathological data of 145 colorectal cancer patients.
From: Enhancing the landscape of colorectal cancer using targeted deep sequencing
Clinicopathological parameters | Number of patients (N = 145, %) | |
|---|---|---|
Sex | Male | 76 (52.4) |
Female | 69 (47.6) | |
Age | ≥ 60 | 78 (53.8) |
< 60 | 67 (46.2) | |
Tumor site | Right colon | 45 (31.0) |
Left colon | 47 (32.4) | |
Rectum | 53 (36.6) | |
T stage | Tis | 2 (1.4) |
T1 | 3 (2.1) | |
T2 | 6 (4.1) | |
T3 | 89 (61.4) | |
T4 | 45 (31.0) | |
N stage | N0 | 35 (24.1) |
N1 | 47 (32.4) | |
N2 | 63 (43.5) | |
M stage | M0 | 83 (57.2) |
M1 | 62 (42.8) | |
Stage | 0 | 2 (1.4) |
1 | 7 (4.8) | |
2 | 17 (11.7) | |
3 | 57 (39.3) | |
4 | 62 (42.8) | |
Lymphatic invasion | Negative | 46 (31.7) |
Positive | 81 (55.9) | |
Not available | 18 (12.4) | |
Vascular invasion | Negative | 80 (55.2) |
Positive | 47 (32.4) | |
Not available | 18 (12.4) | |
Perineural invasion | Negative | 69 (47.6) |
Positive | 58 (40.0) | |
Not available | 18 (12.4) | |
Differentiation | Well | 12 (8.3) |
Moderately | 104 (71.7) | |
Poorly | 15 (10.3) | |
Not available | 14 (9.7) | |
Follow-up | Recurrence | 37 (25.5) |
Died | 5 (3.4) | |
Chemotherapy | Yes | 129 (89.0) |
No | 16 (11.0) | |
Initial CEAa | ≥ 4 | 70 (48.3) |
< 4 | 72 (49.6) | |
Not available | 3 (2.1) | |
EGFR immunohistochemistry | 0 | 1 (0.7) |
1 + | 54 (37.2) | |
2 + | 54 (37.2) | |
3 + | 26 (17.9) | |
Not available | 10 (7.0) | |
